Stay updated on ADI-PEG 20 with Gemcitabine/Docetaxel in Sarcomas/Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the ADI-PEG 20 with Gemcitabine/Docetaxel in Sarcomas/Lung Cancer Clinical Trial page.

Latest updates to the ADI-PEG 20 with Gemcitabine/Docetaxel in Sarcomas/Lung Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page revision was updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check25 days agoChange DetectedRevision: v3.4.3 was added and the previous revision label v3.4.2 was removed. This update is a minor maintenance change and does not affect study details.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision: v3.4.2 was added. The previous government funding-status notice and Revision: v3.4.1 were removed.SummaryDifference0.4%

- Check61 days agoChange DetectedAdded a system-wide notice about a lapse in government funding affecting site updates and directing users to cc.nih.gov and opm.gov for status. Updated the site to version v3.4.1 (from v3.4.0).SummaryDifference0.4%

- Check68 days agoChange DetectedThe changes are limited to UI and metadata updates (glossary display, new labels such as 'Last Update Submitted that Met QC Criteria', 'Last Update Posted', 'No FEAR Act Data', and revision 'v3.4.0'), with no changes to core study content, eligibility criteria, outcomes, or contacts. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check82 days agoChange DetectedSite revision tag updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to ADI-PEG 20 with Gemcitabine/Docetaxel in Sarcomas/Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADI-PEG 20 with Gemcitabine/Docetaxel in Sarcomas/Lung Cancer Clinical Trial page.